Canadian Police Seize 120,000+ Cannabis and Psilocybin Products Resembling Name-Brand Products

a word from our sponsors:

advertisement

advertise here

Police in Canada on Tuesday announced they had taken down an organized crime group believed to have produced tens of thousands of counterfeit candy bars, resembling popular name-brand products, that contained cannabis and psilocybin mushrooms, ABC News reports. Police said they seized more than 120,000 cannabis-infused products resembling brand-name products and more than 6.6 pounds of psilocybin mushrooms in the bust. 

Police said the bust included 1,740 psilocybin capsules, more than 400 psilocybin chocolate candies, 2.2 pounds of pressed cannabis resin, over 500 pounds of flower, more than 19 pounds of concentrates, over 5,000 vape cartridges, counterfeit cannabis-laced honey, five vehicles, two ATM machines containing cash, an estimated 164 master cases of contraband tobacco equating to 82,000 packs of cigarettes, over $400,000 in cash, and a shotgun. 

In a statement, Royal Canadian Mounted Police (RCMP) authorities described the products as resembling “professionally manufactured, packaged, and quality-controlled products” that were “produced in the highly unsanitary, and heavily contaminated modular trailers.” 

“A preliminary assessment of the edibles also indicates that they had been treated with unknown amounts of THC, and likely cross-contaminated with other drugs and substances present in the trailers where they were being produced and packaged.” — RCMP in a statement via ABC News 

The search warrants executed by RCMP on October 3 included two dispensaries and five separate residences on Vancouver Island in British Columbia. The warrants were associated with an organized crime group allegedly involved in the production and distribution of illicit drugs and contraband tobacco in Port Alberni and Nanaimo, police said. Six people were arrested in the operation. 

End


Trial Over Nebraska Medical Cannabis Petitions Focuses on Petition Signatures

a word from our sponsors:

advertisement

advertise here

The trial over Nebraska’s two medical cannabis ballot initiatives began Tuesday in Lancaster County District Court, highlighting ballot measures in the state, the different groups involved in the campaign, and notary publics, the Nebraska Examiner reports. Both proposals – which together if approved by voters would legalize medical cannabis in the state – remain on ballots but the trial outcome could invalidate the election results. 

Attorneys for John Kuehn, a former state senator and former State Board of Health member who filed the lawsuit, and Secretary of State Bob Evnen, a defendant in the lawsuit, sought to frame the case around whether the medical cannabis campaign followed state rules. In a legal brief in the case, Evnen, along with Attorney General Mike Hilgers, contend the campaign engaged in “fraud” and the “malfeasance” of notaries involved “strips the presumption of validity” of thousands of submitted signatures. During arguments on Tuesday, Deputy Solicitor General Zach Viglianco claimed that the campaign cheated in obtaining signatures. 

Sydney Hayes, an attorney for the ballot sponsors, argued that plaintiffs don’t have enough evidence of “fraud” and that, at most, one petition contains 706 questionable signatures while the other contains 394 questionable signatures. Advocates need 86,499 valid signatures on both petitions for them to remain valid, and nearly 90,000 signatures were verified on each petition. 

David Wilson Jr., associate general counsel for the Secretary of State’s Office and director of licensing, who oversees the work of notaries in the state, said that notaries give “presumptive evidence” over a matter’s legal validity and must physically witness an “oath” and confirm the identity of whose documents they are notarizing – in this case, the petitions and their signatures.

The Nebraska Attorney General’s Office alleges that thousands of signatures were collected where those requirements weren’t met and Wilson testified that he was unaware of his office having criminal prosecutorial authority over notaries or of circumstances where one invalidated document led to the invalidation of every document approved by a particular notary. At least one notary, Jacy Todd, has been criminally charged and faces 24 counts of alleged malfeasance. Wilson noted that he is unaware of a notary who has ever been criminally charged for malfeasance.

End


New York Judge Says NYC Crackdown on Unlicensed Cannabis Shops Is Unconstitutional

a word from our sponsors:

advertisement

advertise here

A judge in Queens ruled Tuesday that the New York City law enabling local law enforcement to crack down on unlicensed cannabis sales, dubbed Operation Padlock to Protect, is unconstitutional, according to Green Market Report.

In his opinion on the ruling, Queens County Superior Court Justice Kevin J. Kerrigan wrote that when police forcedly closed the Queens-based retailer Cloud Corner, they had violated the shop owner’s right to due process. Specifically, Kerrigan said that New York City Sheriff Anthony Miranda’s decision to ignore an official recommendation against the shop’s permanent closure — stemming from the fact that Cloud Corner had not been open for business when police conducted their raid on the shop — was a “clear violation of due process under the law.”

“The Court acknowledges that the unlicensed sale of cannabis within the City of New York represents an enormous public health concern. This decision should not be interpreted to condone such unlicensed activity. However, summarily shuttering a business for one year, despite the fact that it was exonerated from allegations of illegal activity stands against the cornerstone of American democracy and procedural due process.” — Kerrigan, in the opinion

A spokesperson for Mayor Eric Adams’ (D) office said in a statement that the city plans to appeal the ruling, and that “Illegal smoke shops and their dangerous products endanger young New Yorkers and our quality of life, and we continue to padlock illicit storefronts and protect communities from the health and safety dangers posed by illegal operators.” Operation Padlock to Protect was announced by the mayor in May and the resulting raids have shuttered over 1,200 shops, the spokesperson said.

Meanwhile, the plaintiff’s attorney, Lance Lazzaro, said in the report that the ruling could allow any shop affected by the crackdown to immediately reopen and sue the city for damages related to the forced closures.

At the state level, Gov. Kathy Hochul (D) has stepped up enforcement this year against unlicensed cannabis retailers as part of an effort to help grow New York’s legal, adult-use cannabis market.

End


Multi-State Cannabis Operator Green Dragon Is Shutting Down

a word from our sponsors:

advertisement

advertise here

Colorado-based Green Dragon, a multi-state cannabis company with operations in Colorado and Florida, will shut down operations by next year, according to a KDVR report.

DP Holdings Colorado LLC, the holding company behind Green Dragon, filed notices on October 16 with state officials in Florida and Colorado to warn of impending layoffs. Per the report, Green Dragon’s layoffs will affect all company positions including cultivation, processing, and retail roles, and the layoffs will cover 59 positions in Colorado and 113 in Florida.

The company is also shutting down 17 dispensaries in Colorado and 39 dispensaries in Florida, and the company is expected to sell off its 400,000-square-foot medical cannabis cultivation facility in Florida.

The folding of Green Dragon follows the company’s 2021 merger with Eaze Technologies, Inc. — a cannabis tech firm once valued at $700 million — but Eaze’s assets were purchased at auction in August, and the company’s CEO Cory Azzalino announced a few weeks ago that the company will “wind down operations” by the end of the year with layoffs coming for nearly 500 employees.

Additionally, the closure follows a recent downturn in Colorado cannabis sales: the state reported just under $109 million in sales through August this year, the report said, while last year the state recorded $132.45 million through the same period.

End


The 2024 Election and Cannabis Legalization: A Critical Turning Point

a word from our sponsors:

advertisement

advertise here

As the 2024 election approaches, BGM recognizes the pivotal role it could play in shaping the future of cannabis legalization across the United States. Matthew Schweich, the Executive Director of the Marijuana Policy Project and a prominent cannabis reform advocate, offered insightful commentary on the potential impacts of the election on cannabis policy. Schweich’s observations reveal that no matter the outcome of the election on November 5, significant developments for the cannabis industry are likely, but challenges remain. In this blog, we’ll delve into Schweich’s key points and explore the election scenarios that could reshape the future of cannabis legalization in the United States.

In this blog, we explore Schweich’s perspective on the possible election outcomes and what they could mean for cannabis businesses nationwide. We share our perspectives and provide insight into the ever-changing cannabis industry landscape that BGM helps clients navigate every day.

Bipartisan Support for Legalization: A Milestone in 2024

One of the most striking aspects of the 2024 election, according to Schweich, is that both major presidential candidates from the Democratic and Republican parties support cannabis legalization. This bipartisan backing marks a significant shift in U.S. political dynamics. As Schweich remarked, “That’s something that I think would have shocked a lot of people 20 years ago, probably even ten years ago, to have the Democrat and the Republican both supporting this policy.”

This widespread support, he noted, reflects a dramatic change in public opinion and political establishment views over the past decade. Just three elections ago, in 2012, no states had legalized cannabis for adult use. Fast forward to 2024, and 24 states have fully legalized cannabis, a clear indication of the cannabis reform movement’s influence and persistence.

Former President Donald Trump’s residency in Florida also played a pivotal role in eliciting his stance on cannabis legalization, as the issue was placed directly in front of him via a statewide initiative. This direct interaction between local politics and federal influence demonstrates the growing importance of cannabis as a national issue, rather than just a state-by-state battle.

The Impact of Rescheduling: Step Forward, But Not Far Enough

In recent months, the Biden administration initiated the process of rescheduling cannabis to Schedule III. This move is significant, but Schweich is quick to point out that it falls short of what the cannabis industry needs. “I think it should be descheduled entirely,” he commented. “Even as a Schedule III drug, it’s going to be considered more dangerous than Xanax.” Schweich emphasized that this classification remains problematic because, in his view, cannabis poses far less danger and addiction risk compared to certain other Schedule III substances.

However, he acknowledged that rescheduling would offer some relief for cannabis businesses, particularly about the burdensome 280E tax regulation. If cannabis is reclassified under Schedule III, businesses could potentially start deducting standard operating expenses, significantly easing financial strains in the industry. Schweich noted, “That’s a huge potential impact, but the cannabis industry knows that more \work needs to be done at the federal level.”

The Role of Federal Legislation: The Next Major Milestone

While rescheduling cannabis is a positive step, Schweich is adamant that the next significant development for the cannabis movement must come in the form of comprehensive federal legislation. Such a law would address lingering issues related to federal policy, mainly banking restrictions and tax regulations that have hampered the cannabis industry for years. The cannabis sector remains largely cash-based due to the lack of access to traditional financial services, which Schweich described as a significant obstacle to growth and safety.

Looking ahead to the potential election outcomes, Schweich mapped out four possible scenarios, ranking them in order of the likelihood for advancing cannabis legislation:

  1. Democrats Control the White House and Congress: According to Schweich, this scenario offers the most promising path forward for federal cannabis reform. Suppose Vice President Kamala Harris wins the election, and the Democrats retain the House and Senate control. In that case, there’s a strong chance of passing a comprehensive federal bill that could legalize cannabis nationwide. Schweich believes this would be the most favorable outcome for the cannabis industry, as it would provide the political alignment needed to push through significant reform.
  2. Republicans Control the White House and Congress: Schweich ranked this as the second most likely scenario for achieving federal reform. He noted that a Republican-controlled Congress and White House under former President Trump could create a more functional system of government, allowing for more streamlined policymaking. However, Trump’s views on cannabis differ significantly from those of many Republican members of Congress, which could complicate the passage of federal cannabis legislation.
  3. Split Government with Trump as President: Schweich expressed cautious optimism in this case. He explained that a Trump presidency with a split Congress could still result in some federal cannabis reform, mainly if Republicans see political advantage in supporting the issue. However, Schweich believes that partisan politics might get in the way, limiting the likelihood of significant progress.
  4. Split Government with Harris as President: Schweich ranked this scenario as the least likely to result in federal cannabis reform. If Harris wins the presidency, but faces a Republican-controlled Congress, Schweich predicts widespread gridlock. “I think if Vice President Harris wins the Presidential election and Republicans control Congress, they’re going to wage a war against her that has nothing to do with cannabis,” he warned. The deeply entrenched partisanship could prevent any meaningful cannabis legislation from passing.

The Filibuster: A Key Obstacle

One of the significant barriers to federal cannabis reform, according to Schweich, is the filibuster in the Senate. With the filibuster requiring 60 votes to pass most legislation, many policy efforts die before they even have a chance to gain momentum. “The filibuster is the enemy of policymaking,” Schweich stated. “It is a mutation of the legislative process in Congress and kills everything.”

Schweich argued that the filibuster prevents thoughtful, well-crafted laws from being passed and hinders progress on issues like cannabis legalization, which enjoys broad public support but faces institutional roadblocks.

State-Level Initiatives: An Optimistic Outlook

Beyond the federal landscape, Schweich is optimistic about the success of state-level cannabis initiatives. In the 2024 election, Florida, North Dakota, and South Dakota are all expected to vote on cannabis legalization. Schweich is cautiously optimistic about all three states, particularly noting that turnout will be crucial. Florida, however, presents a unique challenge due to its 60% threshold for passing ballot initiatives, which Schweich described as “difficult in any state on any issue.”

Nevertheless, Schweich predicted that all three states have a strong chance of passing legalization measures, which would mark yet another milestone in the steady march toward national cannabis legalization.

The Future of the Cannabis Industry Hangs in the Balance

As the 2024 election looms, the future of cannabis policy in the United States remains uncertain but full of potential. Schweich’s insights highlight both the progress made and the obstacles that still remain and stand in the way. While rescheduling cannabis is a step in the right direction, comprehensive federal legislation remains the ultimate goal. Whether that goal is achieved will depend on the outcome of this election and the ability of lawmakers to overcome partisan gridlock.

As Schweich put it, “The cannabis industry knows that work needs to be done at the federal level,” and this election could be a turning point for the entire movement.

If your cannabis business is navigating the evolving regulatory landscape or preparing for the potential changes, BGM is here to help. Our team of experts stays ahead of industry trends to provide guidance on compliance, tax strategies, and long-term planning. Don’t wait for the 2024 election results to take action—reach out to BGM today for tailored advice to keep your business on track. Contact us to schedule a consultation and explore how we can support your cannabis business goals.

End


C4 USA Announces Expansion, Strengthening Its Position in Premium Cannabis Market

a word from our sponsors:

advertisement

advertise here

C4 USA, the trailblazer in high-quality cannabis cultivation, proudly announces an unprecedented leap forward, expanding its operations to over 100,000 square feet of mature canopy. This monumental achievement marks a new chapter in C4 USA’s quest to dominate the cannabis industry, redefining the future of cannabis cultivation on a scale that few can match.

This is not just another expansion. This is a game-changer. By doubling down on innovation and cutting-edge technology, C4 USA has created a facility that sets new benchmarks for quality, consistency, and production capacity. With this expansion, the company can now meet soaring demand while elevating the consumer experience with premium, top-tier cannabis like never before.

“Our expansion to 100,000 square feet is a monumental milestone that underscores our ambition and ability to lead this industry,” said David Bernard, Chief Operating Officer of C4 USA. “We’ve invested in the best talent, the best technology, and a meticulous approach to cultivation that sets us apart. This isn’t just growth—it’s a revolution in how cannabis is produced, and we’re just getting started.”

The expanded cultivation facility, located in Cathedral City, is now one of the largest and most advanced cannabis production centers in California, equipped with cutting-edge technology that ensures precise environmental control and sustainability. From energy-efficient lighting to state-of-the-art irrigation systems, C4 USA is committed to eco-friendly operations while maximizing yield and maintaining exceptional quality standards.

But the excitement doesn’t stop there…

New, exclusive strains are set to be unveiled as a direct result of this expansion, giving C4 USA the ability to introduce unique, highly sought-after products that cater to evolving consumer tastes. These strains will be grown under the most optimal conditions, ensuring superior potency, aroma, and flavor profiles that consistently deliver a premium experience.

The impact of this expansion goes beyond product offerings. C4 USA is poised to create dozens of new jobs in the Cathedral City community, further strengthening its position as a significant economic force in the region. As the company scales up, its commitment to local partnerships and sustainable practices will continue to be a cornerstone of its growth strategy.

C4 USA’s expansion isn’t just about meeting demand—it’s about shaping the future of the cannabis industry. With an unwavering commitment to innovation, sustainability, and excellence, C4 USA is setting a new gold standard for what a cannabis cultivation facility should be.

For cannabis connoisseurs, retailers, and partners, this expansion means greater access to consistent, high-quality cannabis that lives up to C4 USA’s reputation for excellence. For the industry at large, it signals the rise of a true leader—a company that is reshaping the landscape of premium cannabis cultivation.

About C4 USA

C4 USA is a leader in large-scale, premium cannabis cultivation, based in Cathedral City, California. Known for its technological innovation, sustainable practices, and consistent product quality, C4 USA serves both the wholesale and retail markets with an unmatched dedication to excellence. With an ever-expanding portfolio of exclusive strains and cutting-edge cultivation methods, C4 USA continues to set the standard for the cannabis industry.

Sales and Media Contact:

Marcela Valentino

C4 USA  |   WWW.C4USA.COM

831-521-3938

Marcela@c4industry.com

sales@c4industry.com

End


Washington State Auditor Says Cannabis Industry’s Tracking Software Has ‘Failed’

a word from our sponsors:

advertisement

advertise here

In a report released last week, the Office of the Washington State Auditor found that the state’s “stopgap” cannabis industry product tracking technology, Cannabis Central Reporting System (CCRS), has “failed.” The report notes that the state Liquor and Cannabis Board (LCB) has no plans to implement a better system until 2031 – nearly 20 years after cannabis was legalized by voters in the state.    

“A robust, ‘seed-to-sale’ tracking system has been under development for 12 years but has yet to be fully realized. The recreational cannabis market has changed throughout those years. At this time, I believe this report can serve as an important framework through which state leaders can engage with LCB to establish clear goals for ensuring accountability in our modern recreational cannabis system.” — “Evaluating Washington State Oversight of the Cannabis Industry: Follow-up issues,” Office of the Washington State Auditor, 10/22/24 

In its 2018 report, the Auditor’s Office recommended the LCB implement a cannabis tracking system for a data-driven, automated approach to enforcement; however, the recent report found the state “lacks a data tracking system that easily and reliably tracks cannabis products.”  

The report notes that CCRS lacks real-time tracking information and has limited data input protections which means the LCB relies on licensees to report accurate and complete information.  

“Additionally,” the report says, “licensees cannot easily access or correct their data after they upload it, and the lack of a single identification number makes it difficult to track products for quick product recalls.” 

The report suggests a system that tracks cannabis products from seed-to-sale, has consistently reliable and current data, and automated alerts.      

End


National Hemp Association Nets $19.6M USDA Grant to Study Impact of Hemp Cultivation

a word from our sponsors:

advertisement

advertise here

The National Hemp Association (NHA) last week was awarded a $19.6 million grant from the U.S. Department of Agriculture (USDA) to monitor the impact of hemp cultivation in the Chesapeake Bay region. The grant, part of the USDA’s Regional Conservation Partnership Program (RCCP), is designed to address critical conservation challenges such as water quality, soil health, and wildlife habitat protection. 

The initiative will see hemp cultivated on 5,000 acres in the region annually and the NHA said they expect to see reduced nutrient runoff, pesticide contamination, and soil erosion along with the improved overall health of aquatic and terrestrial ecosystems. The Chesapeake Bay Watershed spans more than 64,000 square miles across six states and the District of Columbia and is one of the nation’s most vital ecosystems, supporting wildlife, local communities, and agriculture. However, the NHA notes that it faces significant challenges from pollution and agricultural runoff and by incorporating industrial hemp into regional farming, the organization aims to combat those issues while supporting healthier ecosystems.  

In a statement, Erica Stark, executive director of the National Hemp Association, called the project “an incredible opportunity to demonstrate hemp’s ability to contribute to climate-smart agriculture, help farmers adopt sustainable practices, and expand the industrial hemp industry.”  

The RCCP funding includes $1.5 billion from the USDA and $968 million from private partners, and is part of a broader effort supported by the U.S. Farm Bill and the Inflation Reduction Act of 2022. 

End


New York Office of Cannabis Management Issues ‘Quarantine’ for Caffeine-Infused Cannabis Products

a word from our sponsors:

advertisement

advertise here

Over the summer, the New York Office of Cannabis Management (OCM) issued a stop order for the production of caffeine-infused cannabis pills manufactured by Hudson Cannabis for cannabis brand 1906, the New York Post reports. In a July 24 OCM “quarantine” reviewed by the Post, two OCM inspectors said that “Evidence supports that ingredients used in product are not allowed to be used in cannabis products.” 

The quarantined products include “Go” – a tincture which contains 80 milligrams of caffeine, 2 milligrams of THC and 5 milligrams of CBD – and “Genius,” a pill that includes 20 milligrams of caffeine, 2.5 milligrams of THC, and 5 milligrams of CBD and CBG. Both products have been on the market since February 2023, the report says. The order states that the products “may jeopardize public health or safety.”    

In a statement to the Post, Melany Dobson, co-founder of Hudson Cannabis, said the company is “surprised by this decision from the State to quarantine products that have been on the market for over 18 months, are sold legally in States across the nation, and as far as we know have had zero reported adverse effects.”  

“This type of arbitrary and capricious behavior, preventing the sale of safe and tested products readily available across the country, only serves to benefit the illicit market Governor (Kathy) Hochul claims to care about shutting down.” — Dobson to the Post 

According to state regulations, infusing pure caffeine into cannabis products is not permitted but “naturally occurring caffeine” is allowed.  

“A processor is prohibited from processing any products which… contain any non-phytocannabinoid ingredient that would increase potency, toxicity, or addictive potential, or that would create an unsafe combination, known or unknown, with other psychoactive substances,” the rule states. “This prohibition shall not apply to products containing naturally occurring caffeine, such as coffee, tea, or chocolate.” 

End


Kentucky Holding First Medical Cannabis License Lottery

a word from our sponsors:

advertisement

advertise here

Kentucky officials are holding the first licensing lottery for the state’s medical cannabis industry on Monday, October 28, WLWT5 reports.

The state’s first lottery for medical cannabis licenses will cover cannabis cultivation and processing licenses, with a separate lottery for cannabis dispensary licenses expected sometime later this year. The chances to win a license are quite low — for the 584 cultivator applications received by the state, just 16 licenses will be awarded. Additionally, 344 processor applications were submitted but just 10 licenses will be issued. Overall, the state received nearly 5,000 business applications for the medical cannabis industry but the vast majority (4,076) are for dispensary licenses, of which only 48 will be available.

Today’s license drawing will be live-streamed at 2:00 pm.

Under the medical cannabis program approved by lawmakers in 2023, cultivators will be “responsible for planting, raising, harvesting, trimming, and curing raw plant material” for the state’s medical cannabis industry, while processors will be “responsible for processing and packaging raw plant material into usable product formats,” the report said.

Meanwhile, the state’s first cannabis business license was awarded last month to the testing lab KCA Labs, a Nicholasville-based facility that was previously testing consumer hemp products.

Kentucky Gov. Andy Beshear (D) announced the medical cannabis licensing lotteries in April.

The licensing process is ramping up as officials move to launch Kentucky’s medical cannabis program by January 1, 2025, as directed by state law.

End


South Dakota Cannabis Legalization Bid Polling at 45%

a word from our sponsors:

advertisement

advertise here

Voter support is trailing for the South Dakota ballot initiative to legalize adult-use cannabis, according to a recent survey conducted by Emerson College, KELOLAND Media, and The Hill.

Poll results for Initiated Measure 29, which seeks to legalize the personal possession and cultivation of cannabis for adults aged 21 and older, found 50% of voters planning to oppose the measure, with 45% in favor and 5% undecided.

According to Emerson College Polling’s executive director Spencer Kimball, support for the initiative was highest among younger voters, with 68% of people under 30 in favor. Voters older than 70 were the most opposed, with 64% against.

IM 29 will be the third cannabis legalization initiative posed to South Dakota voters in as many elections but, unlike the previous measures, IM 29 focuses only on legalizing for personal use and would not legalize cannabis sales. Supporters of the measure said they hope lawmakers will legislate rules for a regulated cannabis market if the initiative passes.

In 2022, South Dakota rejected a cannabis legalization initiative with 53% of voters opposing the measure. Two years earlier, however, voters approved two cannabis initiatives in the state — one to legalize medical cannabis, which passed with 70% support, and one to legalize both medical and recreational cannabis, which was approved by 54% of voters. However, the adult-use measure faced legal challenges and was eventually overruled by the Supreme Court for violating the state’s single subject clause for ballot initiatives.

 

End


Poll: 66% of Florida Voters Support Cannabis Legalization Amendment

a word from our sponsors:

advertisement

advertise here

Two-thirds of Florida voters said they will support Amendment 3, the state’s constitutional amendment to legalize adult-use cannabis, when it appears on the ballot in just under two weeks, according to a recent poll. Conducted by the University of North Florida’s Public Opinion Research Lab (PORL), the poll found 66% voter support for legalization, 30% of voters in opposition, and 4% who said they were undecided.

If passed, Amendment 3 would legalize the possession of up to 3 ounces of cannabis flower for adults aged 21 or older. As a constitutional amendment, the issue requires at least 60% voter support to pass.

“After years of polling on marijuana in Florida, both medical and recreational, it is clear that the majority is in favor of legalization. Closing in on election day, despite some heavy campaigning, we’re seeing support for this amendment and is on track to exceed the 60% supermajority required to pass.” — Dr. Michael Binder, PORL faculty director and UNF professor of political science, in a statement

“This poll is another welcome reminder that Amendment 3 is expansively supported and widely seen as the best path forward for Florida,” Smart & Safe Florida spokesperson Morgan Hill said in a press release. “Legalizing recreational adult use marijuana is good for the health, safety and individual freedom of Floridians, and we are energized to continue showing that to voters between now and Election Day.”

The poll also found bipartisan support for the amendment, with 78% of Democrats, 73% of Independents, and 53% of Republicans saying they would vote yes on the issue. Notably, the campaign has pitted the state’s most high-profile Republicans against one another, with Gov. Ron DeSantis (R) and former President Donald Trump (R) — who is a Florida resident — taking opposing sides.

DeSantis launched an opposition campaign earlier this year. The governor also vetoed a proposal in July to restrict intoxicating hemp products in the state, after which many of the state’s hemp operators pledged to donate $5 million to the Republican Party of Florida to help defeat the upcoming legalization vote. This week, DeSantis argued that cannabis supporters should also oppose Amendment 3 because the campaign was largely funded by Trulieve, the state’s largest medical cannabis company which stands to gain significantly more customers if the amendment passes, the Florida Phoenix reports.

Meanwhile, Trump said last month that he would vote yes on Amendment 3, and called on lawmakers “to responsibly create laws that prohibit the use of it in public spaces, so we do not smell marijuana everywhere we go, like we do in many of the Democrat run Cities.” The former president also said that he supports moving cannabis from Schedule 1 to Schedule III under federal law.

End


Unlicensed New York Cannabis Retailer Ordered to Pay $9.5M

a word from our sponsors:

advertisement

advertise here

The owner of an unlicensed cannabis retailer in upstate New York is facing a $9.5 million judgment after investigators found the Rochester-based store had been selling unlicensed cannabis products since at least September 2022, the New York Law Journal reports.

Issued by New York State Supreme Court Justice Frederick Reed, the judgment against George West, who owns Jaydega 7.0 in Canandaigua, was issued after West allegedly ignored a June 2023 notice from the Office of Cannabis Management (OCM) to stop selling cannabis without a license.

As penalty, West is ordered to disgorge more than $1 million in profits from selling unlicensed cannabis products and pay $8.4 million for continuing to sell after being ordered to stop.

New York Attorney General Letitia James thanked OCM for collaborating with the investigation.

“The owner of Jaydega 7.0 refused to follow the law and ignored repeated warnings to stop selling cannabis without a license. Today, George West must pay $9.5 million for violating our laws and hurting local communities. Stores that sell cannabis must abide by rules and regulations just like any other business in New York.” — AG James, in a press release

Meanwhile, after two years of licensed adult-use sales, cannabis tax dollars are finally available to be reinvested into the state, and OCM recently announced it is accepting applications for $100,000 grants — funded by cannabis taxes, with $5 million available in total — for programs seeking to benefit the state’s youth.

End


Maine Recalls Cannabis Products Over Bacterial and Mold Contamination

a word from our sponsors:

advertisement

advertise here

The Maine Office of Cannabis Policy (OCP) has expanded a recent recall of cannabis products sold at retail stores statewide due to the presence of harmful bacteria, yeast, and mold. The recall initially began on October 11, 2024, focusing on the strain “Frosted Cookies,” produced by Massachusetts-based Nova Farms. The contaminated products were sold at 14 adult-use stores between September and early October. As of October 24, 2024, the recall has grown to include more stores and products, including a second strain, “Frozay.”

The recalled products include pre-ground flower, pre-rolls, and blunts, which failed microbial testing for bacteria and mold. Nine additional stores across cities such as Auburn, Bethel, and Portland are reportedly affected, increasing the total number of impacted retailers to 23. The recall covers products sold between August 30 and October 14, 2024.

Consumers are advised to check their packaging for the affected batch numbers and either dispose of the products or return them to the store. Anyone experiencing adverse reactions after using these products, such as sinus issues, dizziness, or fatigue, should seek medical advice immediately.

OCP’s investigation continues as they work to isolate and remove the contaminated cannabis from the market. For a full list of affected retailers and additional information about the failed tests, visit the OCP website.

End


Jetty Extracts

Nate Ferguson: Driving Innovation and Sustainability at Jetty Extracts

a word from our sponsors:

advertisement

advertise here

Nate Ferguson, co-founder and Chief Product Officer at Jetty Extracts, has spent over two decades in the cannabis industry. With Jetty’s 11-year anniversary just passed, the brand is recognized for its commitment to product innovation, sustainability, and overcoming regulatory challenges. In this Q&A, Nate joins us to discuss:

  • His role overseeing product innovation and supply chain management.
  • The early legal risks and lack of regulation faced by cannabis operators.
  • The complex regulations in expanding to new markets like New York and Colorado.
  • Pre-roll production advancements, including the rise of multi-packs and infused pre-rolls.
  • Jetty’s commitment to sustainability through innovative packaging.

For the full interview, continue reading below!


Can you describe your role as co-founder and Chief Product Officer at Jetty Extracts?

Sure. Yeah, my name is Nate Ferguson. I’m co-founder of Jetty, and my title currently is Chief Product Officer. I head up all products at the company, from new product innovation to current products, QC standards, and things like that. I focus heavily on the supply chain, really upstream in the manufacturing process on the cannabis side of things.

Jetty just celebrated our 11th anniversary on October 1st, so we’ve been around a long time. Before that, I owned retail dispensaries in 2009 through 2011, which got shut down by the federal government back in the day. I had cultivation and delivery services as well. So, I’m 20 years into the cannabis industry. I’ve basically seen a lot and know a lot about the plant and cultivation.

What sets Jetty apart is that a lot of us have that old pedigree, that legacy tenure in the industry. We’re close with a lot of growers and breeders, which really helps us put out a product that I feel is better than most of the products on the market because we have a strong focus and good relationships with the cultivators. We focus heavily on what strains we curate, especially for pre-rolls—what are the best crosses when it comes to infused pre-rolls.

So, day-to-day, as a co-founder, I’m doing a little bit of everything. I’ve got my hand in marketing, I’ve got my hand in sales and operations, but my main focus is on product and supply chain.

What challenges did Jetty face in the early years, and how do they compare to the challenges you face today?

Early on, there was a lot less red tape and just a different degree of risk, namely law enforcement. In the first couple of years of Jetty, we had to deal with raids, despite being medical and following Prop 215. There were no ordinances, no regulations in place, and how we operated depended on the mood of local sheriffs or cannabis task forces.

Back then, there were also a lot of small companies that could start easily, sometimes doing dangerous extractions at home. We had to compete with them, and innovation moved fast. Now, it’s the opposite, with more focus on margins and running a healthy business. There’s a lot more red tape, which slows everything down. We’re also expanding into new markets like Colorado, New York, and New Jersey, each with its own set of regulations, which complicates things further.

After becoming so well established in California, how has Jetty managed its expansion into new markets like Colorado, New York, and New Jersey?

Each market comes with its own set of challenges. We’ve been in California for 11 years, one of the most complex markets, so we’re battle-tested. Many of the problems we face in new markets, like an immature supply chain, we’ve already dealt with in California.

Colorado, for example, legalized before California, and because of the climate there, there’s a lot of indoor cultivation. The inputs are great, so we’re excited to work in Colorado, where the supply chain is very mature, and the strains are well known for what works with hash and so on.

In New York, it’s a different story. The state is only a couple of years removed from legalization, and people are trying to cultivate in upstate New York, and it’s snowing on the crops in late September and early October. We’re getting frost, and strains that would normally finish fine in California just aren’t ripening or getting to maturity in New York. So there are still a lot of learnings from the cultivation and supply chain standpoint.

We’re also seeing everyone trying to do so much in New York, which is similar to what we saw in California. Everybody wants to be this big vertical operator, with retail, their own brands, white-labeling, cultivation—you name it.

There are a lot of shiny objects in cannabis. Where Jetty has found success is by focusing solely on being a manufacturer and a brand, doing extraction only, and not branching off into too many things or getting distracted.

That’s something I see happening in New York, and it makes it tough to pick the right partners and work with groups that are hyper-focused and can help Jetty build a sustainable company for the long term.

How does Jetty manage its packaging across different markets, and what role does sustainability play?

We handle all our packaging design and sourcing from our HQ in California. Depending on the market, we either ship it to California first or directly to the other states. The regulations vary by state. For example, New York requires 10% post-consumer recycled packaging, and Colorado has opaque packaging requirements for pre-rolls. It’s challenging to manage, but we prioritize sustainability and innovation in our packaging, which has always been core to Jetty’s identity.

Jetty Extracts Pre-Rolls

How has Jetty approached pre-roll manufacturing, and how would you say the pre-roll market evolved?

Pre-rolls have evolved a lot. Early on, it was manual labor with knock boxes, and many companies bought expensive machines that didn’t work as expected.

Infused pre-rolls, which we specialize in, add extra challenges because of the sticky texture. We’ve finally found a machine that works well for us, producing up to 10,000 pre-rolls a day. We’re seeing a shift towards multi-packs and smaller joints, especially post-COVID, where consumers want personal, single-use joints instead of sharing larger ones.

Jetty is known for its sustainability initiatives. Can you elaborate on these efforts?

The cannabis industry can be extremely wasteful, especially with packaging regulations. We’ve always prioritized sustainability by using recyclable components like post-consumer plastics and craft paper.

We try to balance compliance with eco-friendly solutions, but it’s a work in progress. Disposable vapes, for example, are hard to ignore because they dominate the market, but we’re looking at biodegradable plastics and ways to recycle parts like the lithium battery. It’s tough, but sustainability remains a focus in everything we design.


Thanks for joining us, Nate! To learn more about Jetty Extracts, visit their website.

End


California Has Seized More Than $191M in Illegal Cannabis Since January

a word from our sponsors:

advertisement

advertise here

Since January, California’s Unified Cannabis Enforcement Task Force (UCETF) has seized more than $191 million worth of illegal cannabis across 13 of the state’s counties, with $70.7 million of that total occurring since July. 

In a statement, Gov. Gavin Newsom (D) said that the task force has seized more than 42,000 pounds of cannabis since the start of the year. 

“Through the UCETF, California continues the charge in cracking down on the illicit cannabis market for the safety of consumers and the support of the legal cannabis industry.” — Newsom in a press release 

Bill Jones, chief of the California Department of Cannabis Control’s Law Enforcement Division, noted that during the most recent quarter, UCETF “targeted unlicensed cannabis operators misusing the California cannabis universal symbol on their packaging.” 

“This deceptive practice confuses consumers and puts them at risk,” he said in a statement. “We are stepping up enforcement across the supply chain and shutting these operations down.” 

UCETF was launched in 2022 to combat the California illicit cannabis industry. Since its inception, UCETF has seized and destroyed over 162 tons worth of illegal cannabis worth an estimated $536 million through over 350 operations. The taskforce has also eradicated 526,037 plants, seized 167 firearms, and arrested 59 individuals, according to officials. 

End


Arkansas Supreme Court Rules Medical Cannabis Measure ‘Misleading,’ Votes Will Not be Counted

a word from our sponsors:

advertisement

advertise here

Votes to expand medical cannabis in Arkansas will not be counted after the State Supreme Court ruled that the measure didn’t fully explain what it would do, the Associated Press reports. The decision comes just two weeks before the election but too late to remove the proposal from ballots. 

Justice Shawn Womack, writing for the majority, said the measure did not fully inform voters that it would have stripped the ability of lawmakers to change the 2016 constitutional amendment to legalize medical cannabis in the state. 

“This decision doomed the proposed ballot title, and it is plainly misleading.” — Womack in the decision 

The 4-3 decision by the court also said the measure did not inform voters that, if approved, the amendment would legalize up to an ounce of cannabis possession for any purpose if cannabis were legalized federally. 

In a dissent, Justice Cody Hiland said the court was ignoring precedent by ruling the measure’s wording was misleading. 

“Long ago, this court established definitive standards for evaluating the sufficiency of popular names and ballot titles,” Hiland wrote. “This court has not deviated from those standards until today.” 

In a statement, Arkansans for Patient Access, the group behind the measure, said they are “deeply disappointed” by the decision, adding that “It seems politics has triumphed over legal precedent.”  

 

End


American Institute of CPAs Asks Feds for Guidance on Cannabis Rescheduling

a word from our sponsors:

advertisement

advertise here

The American Institute of CPAs (AICPA) on Tuesday sent a letter to the Department of Treasury and Internal Revenue Service (IRS) requesting guidance for cannabis businesses as the federal government moves to reschedule cannabis from a Schedule I drug under the Controlled Substances Act to a Schedule III. Under the reforms, state-approved cannabis businesses would no longer be subject to section 280E of the tax code. 

In a statement, Melanie Lauridsen, vice president of tax policy and advocacy for the AICPA, said that “Since the beginning of the decriminalization and legalization of marijuana across a growing number of states, cannabis businesses and their CPAs have struggled to walk the tightrope of an industry that is locally legal, but federally illegal.” 

“It’s imperative that the federal government’s tax administration bodies provide guidance to these profitable businesses and their advisors in advance of the rescheduling of marijuana to help ensure a clear understanding of their federal tax obligations and mitigate non-compliance.” — Lauridsen in a press release 

In the letter, the organization makes several recommendations to officials, including retroactive treatment for expenses previously subject to section 280E, clarifying issues stemming from prior section 280E disallowance, uniform tax treatment among cannabis businesses, and that the Treasury Department and IRS offer a voluntary disclosure program for cannabis businesses that would no longer be subject to section 280E as a result of the rescheduling of cannabis.

End


Utah Poll Finds 50% Voter Support for Adult-Use Cannabis Legalization

a word from our sponsors:

advertisement

advertise here

A public opinion poll conducted earlier this month in Utah found that half of state voters support fully legalizing adult-use cannabis, FOX 13 reports.

The poll, conducted by Noble Predictive Insights on behalf of the Utah Patients Coalition, found that about 50% of Utah voters support the legalization of adult-use cannabis. In comparison, 38% of voters believe that only medical cannabis should be available, 9% believe that cannabis should be prohibited entirely, and just 3% were “not sure.” Support for adult-use cannabis was highest (60%) among younger voters and lowest (29%) among those aged 65+, while middle-aged respondents were split almost evenly on the issue (49% in favor).

Desiree Hennessy, the executive director for the Utah Patients Coalition, said the poll was designed to gauge public opinion on the state’s medical cannabis program — and on cannabis reforms in general.

“We’re not even just talking patients. We’re talking Utahns who are up for a recreational or adult-use market in Utah. That is surprising, but it’s not surprising after you’ve watched what’s happened with the program.” — Hennessy, via FOX 13

Utah voters opted to legalize medical cannabis in 2018 but state lawmakers promptly passed legislation to replace the voter-approved program, and it took two years for the state’s first dispensaries to open.

Meanwhile, a study published in April found that about 60% of Utah medical cannabis patients obtain their cannabis from outside the state’s legal market, primarily via illicit or out-of-state sources.

End


Alabama Judge Appoints Mediator to Resolve Medical Cannabis Licensing Dispute

a word from our sponsors:

advertisement

advertise here

Montgomery Circuit Judge James Anderson on Tuesday appointed a mediator in the legal dispute over Alabama’s attempts to award medical cannabis operator licenses, ABC News reports.

Anderson appointed retired Circuit Judge Eugene Reese to the case, writing that mediation “is appropriate in this case and could result in the speedy and just resolution of the dispute.” The argument stems from a series of lawsuits against the Alabama Medical Cannabis Commission’s (AMCC) licensing efforts for the state’s medical cannabis program, which lawmakers approved in 2021.

The AMCC first attempted to issue medical cannabis licenses in June 2023 and since then, regulators have licensed medical cannabis cultivators, processors, transportation services, and a testing lab. However, even though some cultivators have already started growing, the licenses for integrated operators — which cover the combined cultivation, manufacturing, and retail of medical cannabis — have been repeatedly blocked by lawsuits.

The lawsuits cover a variety of complaints including that there were “inconsistencies in the tabulation of [applicants’] scoring data;” that the AMCC had violated the state’s open meetings law; that officials had no right to revoke licenses that were awarded then retracted following the discovery of the aforementioned data error; that regulators had wrongfully implied the owner of a company had been previously convicted of a crime; and that regulators unfairly excluded a company’s application from the second licensing round. Most recently, one of the companies suing the Alabama Medical Cannabis Commission last month asked a judge to toss the agency’s attempts to award cannabis licenses and declare the regulators’ appeal process void.

Previously, state cannabis regulators and licensees asked for a court order to allow the state’s medical cannabis program to proceed.

Meanwhile, thousands of medical cannabis patients in Alabama have been left without legal access for more than a year since regulators first attempted to issue the licenses.

End


Study: CBD Kills 100% of Yellow Fever Mosquito Larvae

a word from our sponsors:

advertisement

advertise here

A study published in the journal Insects found that hemp-derived CBD killed both species of yellow fever mosquito in their larval phase, including one that had developed insecticide resistance. The team, from The Ohio State University, pulverized air-dried hemp leaves into a fine powder soaked in methanol to reach the desired CBD concentrations.

The researchers found that CBD killed the insects within 48 hours.

In an interview with Ohio State News, Erick Martinez Rodriguez, lead author of the study and a graduate student in entomology, noted that “Mosquitoes are one of the deadliest animals in the world, mainly because as adults they serve as vectors of disease.”

“If you compare the amount of hemp extract needed to kill 50% of the population to other synthetic conventional insecticides, it is on the high side, but when you compare it side-by-side to other natural extracts we have tested in our lab, only a relatively low amount is required to produce high mortality values in larvae.” — Martinez Rodriguez to Ohio State News

Peter Piermarini, co-author of the study and a professor of entomology, told Ohio State News that more research is needed to investigate whether hemp and CBD would target organisms like honey bees or other pollinating insects that scientists don’t want to kill or disrupt by introducing potentially harmful additives to the environment.

“CBD is a compound that appears to be safe for people and our companion animals to ingest,” Piermarini said in the report. “It’ll be interesting to learn more about how CBD interacts with various proteins in mammals and insects to understand why it’s safe for people but not insects.”

Conventional synthetic insecticides are chemical tools for killing mosquito larvae populations, but overuse has led to both insecticide resistance and other negative environmental effects.

End


Candidates for Indiana Governor Support Cannabis Law Reforms but Have Different Views on Policy

a word from our sponsors:

advertisement

advertise here

The candidates for Indiana governor have each backed some form of cannabis legalization in the state but have different views on what the industry should look like, the Chicago Tribune reports. The three candidates include Republican U.S. Senator Mike Braun, Democratic candidate and former Indiana Superintendent of Public Instruction Jennifer McCormick, and Libertarian Donald Rainwater. 

McCormick has indicated she would first establish an Indiana Cannabis Commission which would be tasked with overseeing the industry and creating regulations. She told the Tribune that she is “a firm believer” that Indiana is “losing out on so many tax dollars and lots of jobs.” 

“More importantly,” she added, “we’ve got a lot of Hoosiers that are saying, medically, they want that option.”  

Braun said he is open to legalizing cannabis for medical use but that he would work with law enforcement on the reforms. 

“I think when it comes to medical marijuana there are a lot of groups – veterans and others – that really find beneficial use from it. It’s been cascading across the country. If the legislature takes it up, I’m going to be listening carefully and probably favorably disposed towards medical use of marijuana.” — Braun to the Tribune 

Rainwater said he would back a policy to decriminalize and legalize cannabis broadly and expunge the criminal records of anyone with a non-violent cannabis-related arrest.  

“Any reason given for continuing to criminalize the use of medical or recreational cannabis just doesn’t make sense,” Rainwater told the Tribune. He added that he would support reducing “a lot of the restrictive, monopolistic regulations” on the state’s hemp industry which he said would benefit hemp farmers   

According to FiveThirtyEight polling, Braun leads the race between 3 and 9 points over McCormick while Rainwater garners between 6% and 9% of the vote. 

End


New Jersey Bill Would Allow People to Voluntarily Bar Themselves from Cannabis Dispensaries

a word from our sponsors:

advertisement

advertise here

A bill proposed in New Jersey would create a program to allow individuals to voluntarily prohibit themselves from buying cannabis at licensed dispensaries, NJBiz reports. Under the measure, people would be able to add or remove themselves from a self-exclusion list and would direct the Cannabis Regulatory Commission (CRC) to create guidance to remove self-excluded people from cannabis advertising and promotions. 

State Sen. Vincent Polistina (R), the bill sponsor, told NJBiz that the law could help people in recovery from drugs from relapsing.   

“From working with some of the organizations down here that are dealing with an increase in substance abuse issues and dependence issues, they thought this could be a measure that could potentially help people that go through recovery and don’t want to relapse. This would give them the ability to voluntarily get themselves on a list that would prevent them from going into dispensaries.” — Polistina to NJ BIZ 

Under the proposal, there are no consequences for dispensaries that do not cross-reference the list and sell to someone on the list. 

The state has a similar list for the state’s casinos, a registry which over the past 11 years has grown from 1,061 people to 29,256, the report says. Under that law, casinos are fined for allowing people on the self-exclusion list to gamble.  

The bill is currently in the Senate Judiciary Committee. 

End


U.S. Army Bans Use of Hemp-Derived Delta-8 THC Products

a word from our sponsors:

advertisement

advertise here

The U.S. Army has updated its drug policy to specifically ban delta-8 THC and other intoxicating hemp-derived cannabinoids, Marijuana Moment reports.

The Army first ruled against the use of hemp products in 2020 due to their potential to cause a failed drug test. However, those guidelines were issued before delta-8 THC and other hemp-derived cannabinoids had become more readily available — and now, intoxicating hemp products that behave very similar to cannabis are widely available online and in retailers across the country.

Specifically, the new rules ban “synthetic cannabis and other tetrahydrocannabinol (THC) substitutes that have no known application other than mimicking the effects of THC in the human body.”

“Numerous synthetic THC substitutes are now available on the open market in many States. Synthetic cannabis such as Delta-8–THC and other THC substitutes are used in drugs such as ‘spice,’ which are so closely related in action to THC as to make it obvious that synthetic cannabis and THC substitutes will have the same potential for abuse as THC.” — Excerpt from the Army Substance Abuse Program rules

The update mentions that soldiers will undergo random screenings for delta-8 during drug testing. Army officials also warned soldiers against eating foods that contain poppyseeds, which can cause false positives on drug tests, the report said.

End